BG
UTMD icon

BlackRock Group’s Utah Medical Products UTMD Stock Holding History

BlackRock Group’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-4,665
Closed -$227K – 2913
2014
Q3 		$227K Hold
4,665
– – ﹤0.01% 2415
2014
Q2 		$240K Buy
+4,665
New +$240K ﹤0.01% 2414

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
NTP
Nine Ten Partners Evanston, Illinois $308M AUM
MDCM
Morgan Dempsey Capital Management Menomonee Falls, Wisconsin $220M AUM 18.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock Group's UTMD Position: Q4 2014 in Review

BlackRock Group sold out of Utah Medical Products (UTMD) in Q4 2014, closing a stake of 4,665 shares — an estimated $227K sold.

BlackRock Group first reported a position in UTMD in Q2 2014 and held it in 2 quarters. The position peaked at $240K in Q2 2014. 60 funds tracked by Wall St. Rank hold UTMD as of Q4 2014.

  • BlackRock Group reported no remaining Utah Medical Products position as of Q4 2014 after selling out during the quarter.
  • BlackRock Group sold 4,665 Utah Medical Products shares in Q4 2014, an estimated $227K.
  • BlackRock Group first reported a position in Utah Medical Products in Q2 2014 and held it in 2 quarters.
  • BlackRock Group's Utah Medical Products position peaked at $240K in Q2 2014.
  • 60 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2014.

Based on BlackRock Group's 13F filing for Q4 2014, filed 9 Feb 2015.